Hextar Healthcare Berhad (KLSE:HEXCARE)
Malaysia · Delayed Price · Currency is MYR 0.0850
+0.0100 (13.33%)
At close: Feb 26, 2026
Hextar Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 148.11 | 146.95 | 154.76 | 174.97 | 509.95 |
Other Revenue | - | 2.75 | 2.15 | 5.42 | 4.72 |
| 148.11 | 149.7 | 156.91 | 180.38 | 514.67 | |
Revenue Growth (YoY) | -1.06% | -4.60% | -13.01% | -64.95% | 23.53% |
Cost of Revenue | 156.42 | 80.7 | 99.53 | 123.17 | 160.09 |
Gross Profit | -8.3 | 69.01 | 57.39 | 57.21 | 354.58 |
Selling, General & Admin | 13.91 | 34.28 | 39.88 | 37.73 | 48.16 |
Other Operating Expenses | 11.21 | 37.67 | 61.16 | 47.55 | 63.13 |
Operating Expenses | 25.12 | 88.92 | 120.52 | 100.21 | 124.62 |
Operating Income | -33.42 | -19.92 | -63.14 | -43 | 229.96 |
Interest Expense | -0.34 | -0.27 | -0.5 | -0.2 | -0.1 |
Interest & Investment Income | - | 0.08 | 0.03 | 0.01 | 0.01 |
Earnings From Equity Investments | -3.73 | -2.34 | -0.09 | - | - |
Currency Exchange Gain (Loss) | - | -2.25 | 0.15 | -0.11 | 1.71 |
Other Non Operating Income (Expenses) | - | -0.26 | -0.31 | -0.41 | -0.33 |
EBT Excluding Unusual Items | -37.48 | -24.95 | -63.85 | -43.71 | 231.25 |
Gain (Loss) on Sale of Investments | - | - | 0.02 | -0.02 | - |
Gain (Loss) on Sale of Assets | - | -0.19 | -1.22 | -0.03 | 5.95 |
Asset Writedown | - | -0.27 | -8.58 | -20 | -0.42 |
Other Unusual Items | - | 6.43 | -0.02 | 0.58 | - |
Pretax Income | -37.48 | -18.98 | -73.64 | -63.18 | 236.78 |
Income Tax Expense | 7.48 | -5.06 | -9.26 | -7.49 | 51.04 |
Earnings From Continuing Operations | -44.96 | -13.92 | -64.38 | -55.69 | 185.74 |
Net Income | -44.96 | -13.92 | -64.38 | -55.69 | 185.74 |
Net Income to Common | -44.96 | -13.92 | -64.38 | -55.69 | 185.74 |
Net Income Growth | - | - | - | - | 41.60% |
Shares Outstanding (Basic) | 1,102 | 1,045 | 1,002 | 895 | 852 |
Shares Outstanding (Diluted) | 1,102 | 1,045 | 1,002 | 895 | 852 |
Shares Change (YoY) | 5.49% | 4.28% | 11.94% | 5.08% | 6.13% |
EPS (Basic) | -0.04 | -0.01 | -0.06 | -0.06 | 0.22 |
EPS (Diluted) | -0.04 | -0.01 | -0.06 | -0.06 | 0.22 |
EPS Growth | - | - | - | - | 33.42% |
Free Cash Flow | 11.88 | -22.4 | -28.74 | -34.96 | 99.09 |
Free Cash Flow Per Share | 0.01 | -0.02 | -0.03 | -0.04 | 0.12 |
Gross Margin | -5.60% | 46.10% | 36.57% | 31.71% | 68.89% |
Operating Margin | -22.56% | -13.30% | -40.24% | -23.84% | 44.68% |
Profit Margin | -30.35% | -9.30% | -41.03% | -30.87% | 36.09% |
Free Cash Flow Margin | 8.02% | -14.96% | -18.32% | -19.38% | 19.25% |
EBITDA | -17.92 | -4.42 | -45.91 | -28.57 | 242.47 |
EBITDA Margin | -12.10% | -2.95% | -29.26% | -15.84% | 47.11% |
D&A For EBITDA | 15.49 | 15.49 | 17.23 | 14.43 | 12.51 |
EBIT | -33.42 | -19.92 | -63.14 | -43 | 229.96 |
EBIT Margin | -22.56% | -13.30% | -40.24% | -23.84% | 44.68% |
Effective Tax Rate | - | - | - | - | 21.56% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.